Abstract

Molecular genetic studies of the effects of rare, pathogenic mutations have provided deep insights into mechanisms of causation for all forms of autism spectrum disorder (ASD) and highlight a new opportunity to specify treatment, prognosis, family recurrence risk, and the prospective management of common “comorbidities” that exacerbate the severity of impairment in ASD.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call